
Illustration: Reuters
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
Topics
AstraZeneca | Pharma sector | Companies

Illustration: Reuters
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
AstraZeneca Pharma India on Wednesday said Gagandeep Singh Bedi has resigned from the post of managing director.
The drug firm said it has approved the appointment of Sanjeev Panchal as its managing director for a period of three years with effect from January 1, 2023.
Panchal had joined AstraZeneca Pharma in February 2003 as Brand Associate and progressed through several positions in India, Indonesia, Asia Pacific and the international region, based in Singapore and the United Kingdom (UK), it said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
First Published: Wed, December 14 2022. 21:58 IST
Revolut has spent much of its life insisting that it is more than a bank. In Australia, it has now decided that becoming... Read more
Artificial intelligence is no longer something banks discuss as a distant possibility. It is already working behind the ... Read more
ClearBank has spent much of the past decade building the technology and regulatory infrastructure needed to challenge so... Read more
ClearBank’s progress shows that modern clearing and banking infrastructure can become a sizeable and profitable busine... Read more
There is something quietly symbolic about JPMorgan Chase choosing Berlin as its gateway into continental Europe. In a fo... Read more
There is a moment in every bull run when the narrative starts to fray. Not with a crash, not with a scandal, but with so... Read more